We develop early clinical assets to advance into the clinic with pharmaceutical partners

Eleva is opening a realm of unprecedented therapies by harnessing an inconspicuous but incredibly efficient partner: Bryophyta, more commonly known as moss. This ancient organism holds the key to the therapies of the future. Moss plants are not only able to produce the most complex and demanding proteins; with their unique characteristics, they downright invite easy, stable engineering and reliable output. We have harnessed its outstanding features to create drug candidates and take them to clinical stages, ready for a bright future.